LinkedIn Profile

Access NEURONIX historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:neuronix 2747300 Mar 9th, 2018 12:00AM Neuronix Medical 536 18.00 Open Medical Devices Mar 9th, 2018 08:36AM Mar 9th, 2018 08:36AM Open Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 17th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 16th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 15th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 14th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 13th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 12th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 11th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 10th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services
private:neuronix 2747300 Feb 9th, 2018 12:00AM Neuronix Medical 448 15.00 Open Medical Devices Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Neuronix is a dynamic, leading edge Medical Technology company focused on one of the world’s most significant unmet medical needs: Alzheimer’s disease. Established in 2008, Neuronix develops new methods for modifying the course of treatment for Alzheimer’s Disease (AD) and offers hope and the potential for long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by leading researchers and physicians in the field, Neuronix’s neuroAD Therapy System recently completed a multi-center clinical study in the United States and is commercially available in clinics in Europe and Asia. The neuroAD Therapy System is based on the company’s core Non Invasive patented technology and CE-marked for the treatment of mild to moderate Alzheimer’s Disease. This novel technology uses Magnetic Stimulation, concurrently interlaced with Cognitive Training and directed at specific brain regions affected by Alzheimer’s Disease. This combination induces LTP (Long-Term Potentiation), which is associated with learning and memory processes. Results have indicated measurable cognitive improvement, after just a few weeks of treatment, which has shown to last for up to one year. Several published studies performed at the Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA), Israel, and other locations showed statistically significant clinical results compared with placebo following 6 weeks of daily 1-hr sessions. neuroAD Therapy System is CE-marked for commercial use in Europe for the treatment of Alzheimer patients. A multi-center clinical study was recently completed in the US, and will be used to support a submission seeking US-FDA clearance. Neuronix is a privately-held company with headquarters in Israel, and subsidiaries in USA and UK. Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.